American Scientific Resources (ASFX)

[Streett]

Actually, it was posted in the corporate update back in December 2010...

FYI

I will try to provide a link... but in the meantime, here is the direct quote from the update...

"Furthermore, Bayer asked ASFX to design a global solution for Kogenate, Bayer’s infusion drug treating hemophiliacs. A Disintegrator variant has been engineered, developed and presented to Bayer on Jason Roth and Marc Massoglia’s recent trip to France.
The Company continues to co-develop the NGO project with its partners in manufacturing, distribution and the NGO community."

Respectfully submitted....
CW